CANCER VACCINE DESIGNED FROM HOMOLOGOUS FERRITIN-BASED FUSION PROTEIN WITH ENHANCED DC-T CELL CROSSTALK FOR DURABLE ADAPTIVE IMMUNITY AGAINST TUMORS

Cancer vaccine designed from homologous ferritin-based fusion protein with enhanced DC-T cell crosstalk for durable adaptive immunity against tumors

Peptide vaccines based on tumor antigens face the challenges of rapid clearance of peptides, low immunogenicity, and immune suppressive tumor microenvironment.However, the traditional solution mainly uses exogenous substances as adjuvants or carriers to enhance innate immune responses, but excessive inflammation can damage adaptive immunity.In the

read more



Acetoacetate reduces growth and ATP concentration in cancer cell lines which over-express uncoupling protein 2

Abstract Background Recent evidence suggests that several Vests human cancers are capable of uncoupling of mitochondrial ATP generation in the presence of intact tricarboxylic acid (TCA) enzymes.The goal of the current study was to test the hypothesis that ketone bodies can inhibit cell growth in aggressive cancers and that expression of uncoupling

read more